CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clinical Data Update on May 8, 2024
Stock Information for Kandi Technologies Group Inc.
Loading
Please wait while we load your information from QuoteMedia.